Liquid biopsy in cancer has gained momentum in clinical research and is experiencing a
boom for a variety of applications. There are significant efforts to utilize liquid biopsies in …

Extracellular vesicles (EVs) and particles (EPs) have recently emerged as active carriers of
molecular biomarkers and mediators of intercellular communication. While most …

The study of extracellular vesicles (EVs), especially in the liquid biopsy field, has rapidly
evolved in recent years. However, most EV studies have focused on RNA or protein content …

Precision medicine has transformed the way urothelial carcinoma is managed. However,
current practices are limited by the availability of tissue samples for genomic profiling and …

Extracellular vesicles (EVs) are small membrane vesicles released by all cells and involved
in intercellular communication. Importantly, EVs cargo includes nucleic acids, lipids, and …

Exosomes are lipid bilayer vesicles with a diameter of 40–100 nm secreted by almost all
cells. They have been found play crucial regulatory roles in various diseases. With the …

Urine cell-free DNA (cfDNA) is a valuable noninvasive biomarker for cancer mutation
detection, infectious disease diagnosis (eg, tuberculosis), organ transplantation monitoring …

Simple Summary We reviewed characterization and the role of DNAs derived from
extracellular vesicles focusing on its use for identifying biomarkers. Extracellular vesicles …

Liquid biopsy technologies have seen a significant improvement in the last decade, offering
the possibility of reliable analysis and diagnosis from several biological fluids. The use of …

Liquid biopsy is a minimally invasive biopsy method that uses molecules in body fluids as
biomarkers, and it has attracted attention as a new cancer therapy tool. Liquid biopsy has …